InvestorsHub Logo
Followers 5
Posts 1109
Boards Moderated 0
Alias Born 05/02/2014

Re: Revtach post# 73501

Saturday, 07/21/2018 8:37:29 AM

Saturday, July 21, 2018 8:37:29 AM

Post# of 140471
Amazingly, in contrast to so many other startups, Titan has actually developed a real, market worthy technology, functionally prototyped, and supported by patents and professional testing. It has been a long road for both the visionaries and the investors.
But it was mismanaged early on by people with know-how inappropriate to the task (Fowler, Reiza, Hargrove, Randall, and others).

Yet here we are; if we were in the hands of a large medical tech company for the past two years or so, we would already be in FDA testing and reaping the share price benefits of becoming the first competitor to ISRG.

My guess at this point is that McNally will be forced to sell the entire package to someone (for a firesale price)just so the "principals" can walk off with their profit. There it will either fizzle out (ie. bogged down with lawsuits from Columbia, MicroLine, Ximedica, shareholders,or actually become a dominant product).